19295448

Source:http://linkedlifedata.com/resource/pubmed/id/19295448

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0021747, umls-concept:C0024554, umls-concept:C0033167, umls-concept:C0035525, umls-concept:C0085415, umls-concept:C0524910
pubmed:issue	7
pubmed:dateCreated	2009-7-20
pubmed:abstractText	To report our experience with pegylated interferon and ribavirin treatment of hepatitis C virus (HCV) RNA-positive inmates at the Rhode Island Department of Corrections.
pubmed:grant	http://linkedlifedata.com/resource/pubmed/grant/1K24DA022112-01A, http://linkedlifedata.com/resource/pubmed/grant/K24 DA022112-01A2, http://linkedlifedata.com/resource/pubmed/grant/K24 DA022112-04, http://linkedlifedata.com/resource/pubmed/grant/P30 AI042853-02, http://linkedlifedata.com/resource/pubmed/grant/P30-AI-42853
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/19295448
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/7910017
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antiviral Agents, http://linkedlifedata.com/resource/pubmed/chemical/Interferon-alpha, http://linkedlifedata.com/resource/pubmed/chemical/Polyethylene Glycols, http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Ribavirin, http://linkedlifedata.com/resource/pubmed/chemical/interferon alfa-2b, http://linkedlifedata.com/resource/pubmed/chemical/peginterferon alfa-2b
pubmed:status	MEDLINE
pubmed:month	Aug
pubmed:issn	1539-2031
pubmed:author	pubmed-author:AllenScott ASA, pubmed-author:ChewKara WKW, pubmed-author:FellerEdwardE, pubmed-author:RichJosiah DJD, pubmed-author:TaylorLynn ELE
pubmed:issnType	Electronic
pubmed:volume	43
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	686-91
pubmed:dateRevised	2011-11-17
pubmed:meshHeading	pubmed-meshheading:19295448-Adult, pubmed-meshheading:19295448-African Americans, pubmed-meshheading:19295448-Antiviral Agents, pubmed-meshheading:19295448-Drug Therapy, Combination, pubmed-meshheading:19295448-European Continental Ancestry Group, pubmed-meshheading:19295448-Follow-Up Studies, pubmed-meshheading:19295448-Genotype, pubmed-meshheading:19295448-Hepacivirus, pubmed-meshheading:19295448-Hepatitis C, Chronic, pubmed-meshheading:19295448-Humans, pubmed-meshheading:19295448-Interferon-alpha, pubmed-meshheading:19295448-Male, pubmed-meshheading:19295448-Middle Aged, pubmed-meshheading:19295448-Polyethylene Glycols, pubmed-meshheading:19295448-Prisoners, pubmed-meshheading:19295448-Recombinant Proteins, pubmed-meshheading:19295448-Retrospective Studies, pubmed-meshheading:19295448-Rhode Island, pubmed-meshheading:19295448-Ribavirin, pubmed-meshheading:19295448-Treatment Outcome, pubmed-meshheading:19295448-Young Adult
pubmed:year	2009
pubmed:articleTitle	Treatment outcomes with pegylated interferon and ribavirin for male prisoners with chronic hepatitis C.
pubmed:affiliation	Department of Medicine, University of California at San Francisco, San Francisco, CA 94115, USA. kara.chew@ucsf.edu
pubmed:publicationType	Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural